Registered Number:11095242 |
For the year ended 31 March 2024
England and Wales
Unaudited Financial Statements
For the year ended 31 March 2024
MPHARM HOLDINGS LIMITED
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
MPHARM HOLDINGS LIMITED
Statement of Financial Position
31/3/2023
31/3/2024
395,880
156,000
Property, plant and equipment |
16,551
6,463
412,431
162,463
14,925
56,520
Trade and other receivables |
115,526
154,191
59,242
Cash and cash equivalents |
63,837
274,548
189,693
Trade and other payables: amounts falling due within one |
year |
(126,329)
(219,055)
63,364
55,493
Net current assets
Total assets less current liabilities |
467,924
225,827
Trade and other payables: amounts falling due after more |
than one year |
(138,052)
(365,600)
(3,145)
(1,228)
Provisions for liabilities |
99,179
Net assets
86,547
100
100
99,079
86,447
99,179
86,547
Shareholders' funds
For the year ended 31 March 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006 |
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 3
For the year ended 31 March 2024
MPHARM HOLDINGS LIMITED
Statement of Financial Position Continued
These financial statements were approved and authorised for issue by the Board on 04 December 2024 and were signed by: |
The notes form part of these financial statements |
2 of 3
For the year ended 31 March 2024
MPHARM HOLDINGS LIMITED
Notes to the Financial Statements
Statutory Information
MPHARM HOLDINGS LIMITED is a private limited company, limited by shares, domiciled in England and Wales, |
registration number 11095242. |
Principal place of business: |
36 Abel Street
Burnley
Lancashire
BB10 1QR
14 Haworth Grove
Bradford
West Yorkshire
BD9 5PE
The presentation currency is £ sterling. |
Basis of preparing the financial statements
1. Average number of persons employed |
During the year the average number of employees was 11 (2023 : 4)
3 of 3